Drug
Standard TB treatment
Standard TB treatment is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_3
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 32 (50.0%)
N/A2 (50.0%)
Trials by Status
completed250%
recruiting125%
not_yet_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingphase_3
A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery
NCT07136987
recruitingnot_applicable
A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease
NCT06909799
completedphase_3
Optimization of the TB Treatment Regimen Cascade
NCT02153528
completednot_applicable
Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings
NCT00091936
Clinical Trials (4)
Showing 4 of 4 trials
NCT07136987Phase 3
A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery
NCT06909799Not Applicable
A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease
NCT02153528Phase 3
Optimization of the TB Treatment Regimen Cascade
NCT00091936Not Applicable
Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4